Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income $ 1,770,378 $ 1,323,909
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Impairment of goodwill and purchased intangible assets 239,100 219,000
Depreciation and amortization 199,745 201,466
Unrealized foreign exchange (gain) loss and other 19,064 (24,376)
Stock-based compensation expense 123,541 97,392
Net gain on sale of assets (161) 0
Deferred income taxes (150,658) (136,480)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (486,264) (53,247)
Inventories 5,632 (159,608)
Other assets 61,796 (112,392)
Accounts payable 54,617 11,037
Deferred system revenue 86,709 232,307
Deferred service revenue 58,790 74,722
Other liabilities (137,536) (167,748)
Net cash provided by operating activities 1,844,753 1,505,982
Cash flows from investing activities:    
Proceeds from sale of assets 161 5,079
Capital expenditures (152,716) (144,846)
Purchases of available-for-sale securities (1,326,968) (982,642)
Proceeds from sale of available-for-sale securities 238,419 15,235
Proceeds from maturity of available-for-sale securities 1,682,585 628,277
Purchases of trading securities (34,857) (66,007)
Proceeds from sale of trading securities 36,043 64,757
Net cash provided by (used in) investing activities 442,667 (480,147)
Cash flows from financing activities:    
Repayment of debt (750,000) 0
Common stock repurchases (1,217,504) (893,229)
Payment of dividends to stockholders (424,855) (378,366)
Issuance of common stock 47,538 48,433
Tax withholding payments related to vested and released restricted stock units (75,854) (71,242)
Contingent consideration payable and other, net 0 (1,676)
Net cash used in financing activities (2,420,675) (1,296,080)
Effect of exchange rate changes on cash and cash equivalents (5,596) 7,434
Net decrease in cash and cash equivalents (138,851) (262,811)
Cash and cash equivalents at beginning of period 1,977,129 1,927,865
Cash and cash equivalents at end of period 1,838,278 1,665,054
Supplemental cash flow disclosures:    
Income taxes paid, net 458,228 605,434
Interest paid 156,185 138,054
Non-cash activities:    
Contingent consideration payable - financing activities 0 (765)
Dividends payable - financing activities 4,113 3,985
Unsettled common stock repurchase - financing activities 5,500 10,999
Accrued purchases of land, property and equipment - investing activities $ 11,354 $ 18,312